México Mercado de Fraccionamiento de Plasma Tamaño, Participación, Tendencias y Pronóstico por Producto, Sector, Aplicación, Usuario Final y Región, 2026-2034

Overview of the plasma fractionation market in Mexico:

The plasma fractionation market in Mexico reached USD 461.0 million in 2025. Looking ahead, IMARC Group expects the market to reach USD 879.8 million by 2034 , exhibiting a compound annual growth rate (CAGR) of 7.22% during 2026–2034 .  The increasing demand for plasma-derived therapies, the rising incidence of immunodeficiency disorders, and expanded access to healthcare are driving market growth. Furthermore, government support for blood plasma donation, continued advancements in fractionation techniques, increased investment by biopharmaceutical companies, improved supply chains, and greater patient access to critical plasma-based treatments are some of the key factors increasing the market share of plasma fractionation in Mexico.

Plasma fractionation market trends in Mexico:

Expansion of blood donation centers and campaigns to strengthen plasma collection

Mexico is intensifying its national efforts to promote blood and plasma donation as part of a broader strategy to support national plasma fractionation initiatives. Specifically, on September 5, 2024, the Mexican Ministry of Health launched the National Blood System to improve the efficiency of blood donation and resource management at the federal and state levels. This initiative aims to optimize the operations of more than 530 blood banks, 4,500 transfusion services, and 450 collection centers, ensuring the timely delivery of blood, particularly to underserved regions. Furthermore, the Ministry of Health and affiliated institutions such as the National Blood Transfusion Center (CNTS) are launching coordinated campaigns focused on public education, non-monetary donor incentives, and community engagement to increase participation rates. Mobile blood collection units, partnerships with universities, and donor awareness programs are being expanded, especially in urban centers such as Mexico City, Guadalajara, and Monterrey. Furthermore, efforts are increasingly focused on creating a culture of repeat donation, as frequent volunteer donors tend to provide higher-quality plasma with better traceability and safety profiles. This is essential for producing immunoglobulins and clotting factors that meet international standards. In line with this, digital campaigns and initiatives, including mobile apps and SMS donor tracking, aimed at improving appointment scheduling and donor retention, are strengthening the market.

Increased demand for immunoglobulins due to autoimmune and neurological disorders

The demand for immunoglobulin therapies in Mexico is increasing significantly, driven by the growing prevalence of autoimmune diseases such as Guillain-Barr syndrome, primary immunodeficiencies, and chronic inflammatory demyelinating polyneuropathy . According to industry reports, as of March 29, 2024, there were 81 documented cases of acute flaccid paralysis, 34 of which were confirmed as GBS, with four fatalities related to the condition. These figures underscore the critical role of immunoglobulin therapies, which remain a first-line treatment for GBS due to their ability to modulate immune responses and reduce nerve inflammation. This, in turn, is fueling the growth of the plasma fractionation market in Mexico. As diagnostic capabilities improve and awareness spreads among healthcare professionals and patients, the therapeutic use of intravenous and subcutaneous immunoglobulins is increasing markedly. Hospitals and specialist clinics are reporting an increase in prescriptions for these products, which are often essential for treating rare and chronic diseases. Furthermore, clinical guidelines are being updated to reflect new evidence supporting the early and sustained use of immunoglobulins in various indications. These changes are putting pressure on both public procurement systems and private distributors to increase the reliability of supply. This trend is driving investment in both domestic production and more secure import contracts, creating a competitive environment among suppliers seeking long-term institutional buyers.

Segmentation of the plasma fractionation market in Mexico:

IMARC Group offers an analysis of key trends in each market segment, along with national and regional forecasts for 2026-2034. Our report has categorized the market based on product, sector, application, and end user.

Product perspectives:

• Immunoglobulins
• Albumin
• Factor VIII of coagulation
• Coagulation Factor IX

The report offers a detailed breakdown and analysis of the market by product. This includes immunoglobulins, albumin, coagulation factor VIII, and coagulation factor IX.

Industry outlook:

• Private sector
• Public sector

The report also provides a detailed breakdown and analysis of the market by sector. This includes both the private and public sectors.

Application perspectives:

• Neurology
• Immunology
• Hematology
• Others

The report offers a detailed breakdown and analysis of the market based on application. This includes neurology, immunology, hematology, and others.

End-user perspectives:

• Hospitals and clinics
• Clinical research laboratories
• Academic Institutes

El informe también ofrece un desglose y un análisis detallados del mercado en función del usuario final. Esto incluye hospitales y clínicas, laboratorios de investigación clínica e institutos académicos.

Perspectivas regionales:

• Norte de México 
• México Central 
• Sur de México 
• Otros 

El informe también ha proporcionado un análisis exhaustivo de los principales mercados regionales, que incluyen el norte de México, el centro de México, el sur de México y otros.

Panorama competitivo:

El informe de investigación de mercado también ha proporcionado un análisis exhaustivo del panorama competitivo. El informe incluye análisis de la competencia como la estructura del mercado, el posicionamiento de los actores clave, las principales estrategias ganadoras, el cuadro de mando de la competencia y el cuadrante de evaluación de las empresas. También se ofrecen perfiles detallados de las principales empresas.

Cobertura del mercado de fraccionamiento de plasma en México:

Preguntas clave respondidas en este informe:

• ¿Cómo se ha comportado hasta ahora el mercado del fraccionamiento de plasma en México y cómo se comportará en los próximos años?
• ¿Cuál es la distribución del mercado del fraccionamiento del plasma en México por productos?
• ¿Cuál es la distribución del mercado del fraccionamiento de plasma en México por sectores?
• ¿Cuál es la distribución del mercado del fraccionamiento de plasma en México por aplicaciones?
• ¿Cuál es el desglose del mercado del fraccionamiento de plasma en México en función del usuario final?
• ¿Cuál es la distribución del mercado del fraccionamiento de plasma en México por regiones?
• ¿Cuáles son las diferentes etapas de la cadena de valor del mercado del fraccionamiento de plasma en México?
• ¿Cuáles son los principales factores impulsores y los retos del mercado del fraccionamiento de plasma en México?
• ¿Cuál es la estructura del mercado del fraccionamiento de plasma en México y quiénes son los principales actores?
• What is the level of competition in the plasma fractionation market in Mexico?

Main benefits for stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and market dynamics of plasma fractionation in Mexico from 2020 to 2034.
• The research report provides the latest information on market drivers, challenges, and opportunities in the plasma fractionation market in Mexico.
• Porter's Five Forces analysis helps stakeholders assess the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders analyze the level of competition within the plasma fractionation industry in Mexico and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of the major market players.